Cohort Prospective Study of Children With Head and Neck Cystic Malformation Who Are Treated With Intracystic OK432

PHASE4UnknownINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2016

Conditions
CYSTIC MALFORMATION
Interventions
DRUG

Intracystic injection of OK432 under US guiding

Intracystic injection of OK432 under US guiding

Trial Locations (1)

34362

RECRUITING

Department of Otolaryngology, Carmel Medical Center, Haifa

Sponsors
All Listed Sponsors
lead

Carmel Medical Center

OTHER

NCT01699347 - Cohort Prospective Study of Children With Head and Neck Cystic Malformation Who Are Treated With Intracystic OK432 | Biotech Hunter | Biotech Hunter